Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Teriparatide injection is used to treat osteoporosis in postmenopausal women who are at high risk for bone fracture. It reduces the risk of having bone and spine fracture in postmenopausal women with osteoporosis.
Teriparatide injection is also used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for bone fracture or cannot use other osteoporosis treatments.
Teriparatide injection is also used to treat osteoporosis caused by steroid (glucocorticoid) medicine in men and women who are at high risk for bone fracture or cannot use other osteoporosis treatments.
Teriparatide is a synthetic form of the natural human parathyroid hormone. This medicine helps your body to form new bone, increase bone mineral density and bone strength. As a result, it reduces the chance of getting a fracture (broken bone).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
From Mayo Clinic to your inbox
Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health.
ErrorEmail field is required
ErrorInclude a valid email address
To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
Thank you for subscribing
Our Housecall e-newsletter will keep you up-to-date on the latest health information.
Sorry something went wrong with your subscription
Please, try again in a couple of minutes